Carlton South Vic 3053, Australia
Go to Investors Hub
info@radiopharmtheranostics.com
Latest News

Radiopharm Theranostics
Author: Radiopharm Theranostics

RAD 202 receives approval to start Phase 1 therapeutic trial
Response to ASX Aware Letter
Application for quotation of securities – RAD
Notice Under Section 708A
Application for quotation of securities – RAD
Notification of cessation of securities – RAD
Change of Director’s Interest Notices x7
Change of Director’s Interest Notice PH
Completion of preclinical data package for RAD 402
Constitution
Categories
Announcements
Announcements
Annual Reports
Annual Reports
Presentations
Presentations
News
News
Recent News
Analyst ReportsAnnouncementsAnnual ReportsInvestor PresentationsRAD ArticlesUpdates
Tags
Tags
Appendix 2A (1) Appendix 3B (1) Change of Director's Interest Notice (1) Cleansing Notice (1) PDF (24) Periodic Reports (24) Price Sensitive (84) Progress Report (2) Video (3) With Summary (2) With Video (4)
Archives
Archives
RSS RSS
Close
Search

Hit enter to search or ESC to close

cookie By using this website, you agree to our cookie policy. Close